A

ADPT

ADPT

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
ADPT Live QuoteReal-time
$28.46
+$4.04(+16.54%)1M
Day Range$27.62 – $29.23
Open$27.79
Previous Close$28.49
Volume2.21M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$4.64B
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-0.45
Price to Book25.6
Dividend Yield0.65%
Beta (Volatility)2.15
IndustryDIAGNOSTICS & RESEARCH
52-Week RangeCurrent: $28.46 (81%)
Low: $12.00High: $32.21
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$32.57-78.3% upside

Insider Buys

0

$0

Insider Sales

60

$102.03M

Total Volume

$102.03M

100 transactions

Net Activity

$102.03M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
15CONFIDENCE

Sentiment Rating

Heavy Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
R
1

Robins Chad M

CEO, COB

0 buys4 sells

$31.16M total

R
2

Robins Harlan S

Chief Scientific Officer

0 buys6 sells

$27.86M total

R
3

Rubinstein Julie

Pres, COO

0 buys21 sells

$20.21M total

L
4

Lo Francis

Chief People Officer

0 buys8 sells

$10.58M total

B
5

Benzeno Sharon

Chief Commercial Ofc Imm Med

0 buys2 sells

$4.33M total

Trading History
ADPT insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 11, 2026

1 weeks ago

Rubinstein Julie

Pres, COO

COO
Sell35.2K$29.73$1.05M

Nov 11, 2026

1 weeks ago

Bobulsky Susan

Chief Commercial Officer, MRD

C-Level
Sell1.9K$32.00$60K

Oct 27, 2026

3 weeks ago

Rubinstein Julie

Pres, COO

COO
Sell35.6K$28.00$998K

Oct 22, 2026

4 weeks ago

Rubinstein Julie

Pres, COO

COO
Sell35.6K$25.18$897K

Oct 19, 2026

1 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell377.8K$-35643.00$0

Oct 19, 2026

1 months ago

Rubinstein Julie

Pres, COO

COO
Sell35.6K$24.66$879K

Oct 14, 2026

1 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell377.8K$-35643.00$0

Oct 14, 2026

1 months ago

Rubinstein Julie

Pres, COO

COO
Sell35.6K$25.18$897K

Oct 9, 2026

1 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell377.8K$-35643.00$0

Oct 9, 2026

1 months ago

Rubinstein Julie

Pres, COO

COO
Sell35.6K$25.81$920K

Oct 6, 2026

1 months ago

Bobulsky Susan

Chief Commercial Officer, MRD

C-Level
Sell6.4K$30.00$193K

Oct 6, 2026

1 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell377.8K$-35643.00$0

Oct 6, 2026

1 months ago

Rubinstein Julie

Pres, COO

COO
Sell35.6K$26.60$948K

Oct 1, 2026

1 months ago

Lo Francis

Chief People Officer

C-Level
Sell26.8K$28.28$758K

Oct 1, 2026

1 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell377.8K$-35643.00$0

Oct 1, 2026

1 months ago

Rubinstein Julie

Pres, COO

COO
Sell35.6K$28.46$1.01M

Sep 16, 2026

2 months ago

Lo Francis

Chief People Officer

C-Level
Sell115.4K$28.06$3.24M

Sep 16, 2026

2 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell223.4K$-115406.00$0

Sep 15, 2026

2 months ago

Bobulsky Susan

Chief Commercial Officer, MRD

C-Level
Sell1.2K$27.00$32K

Sep 15, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell395.8K$-1195.00$0

Aug 26, 2026

2 months ago

Owen Katey Einterz

Dir

Director
Sell9.6K$26.00$250K

Aug 26, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell78.6K$-9615.00$0

Aug 18, 2026

3 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell46.7K$-30664.00$0

Aug 18, 2026

3 months ago

Hershberg Robert

Dir

Director
Sell30.7K$24.40$748K

Aug 17, 2026

3 months ago

Neupert Peter M

Dir

Director
Sell124.7K$25.15$3.14M

Aug 17, 2026

3 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell2.18M$-600000.00$0

Aug 17, 2026

3 months ago

Robins Chad M

CEO, COB

CEO
Sell600.0K$24.80$14.88M

Aug 10, 2026

3 months ago

Bobulsky Susan

Chief Commercial Officer, MRD

C-Level
Sell3.0K$25.00$75K

Aug 10, 2026

3 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell397.0K$-3000.00$0

Jul 30, 2026

3 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell400.0K$-1299.00$0

Jul 30, 2026

3 months ago

Bobulsky Susan

Chief Commercial Officer, MRD

C-Level
Sell1.3K$24.00$31K

Jul 21, 2026

4 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell812.1K$-492400.00$0

Jul 21, 2026

4 months ago

Robins Harlan S

Chief Scientific Officer

C-Level
Sell492.4K$21.89$10.78M

Jul 16, 2026

4 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell401.3K$-5000.00$0

Jul 16, 2026

4 months ago

Bobulsky Susan

Chief Commercial Officer, MRD

C-Level
Sell5.0K$23.00$115K

Jul 15, 2026

4 months ago

Lo Francis

Chief People Officer

C-Level
Sell105.8K$22.59$2.39M

Jul 15, 2026

4 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell233.2K$-105762.00$0

Jul 2, 2026

4 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell1.02M$-386240.00$0

Jul 2, 2026

4 months ago

Robins Harlan S

Chief Scientific Officer

C-Level
Sell386.2K$22.01$8.50M

Jul 1, 2026

4 months ago

Lo Francis

Chief People Officer

C-Level
Sell95.8K$22.51$2.16M

Jul 1, 2026

4 months ago

Bobulsky Susan

Chief Commercial Officer, MRD

C-Level
Sell487$22.00$11K

Jul 1, 2026

4 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell233.2K$-95842.00$0

Jun 26, 2026

4 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell221.3K$-165802.00$0

Jun 26, 2026

4 months ago

Benzeno Sharon

Chief Commercial Ofc Imm Med

C-Level
Sell165.8K$21.13$3.50M

Jun 25, 2026

4 months ago

Griffin Michelle Renee

Dir

Director
Sell52.1K$20.18$1.05M

Jun 25, 2026

4 months ago

Bobulsky Susan

Chief Commercial Officer, MRD

C-Level
Sell5.0K$20.50$103K

Jun 25, 2026

4 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell406.8K$-5000.00$0

Jun 15, 2026

5 months ago

Robins Harlan S

Chief Scientific Officer

C-Level
Sell106.2K$17.41$1.85M

Jun 15, 2026

5 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell1.41M$-106160.00$0

Jun 11, 2026

5 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell411.8K$-5000.00$0

Jun 11, 2026

5 months ago

Bobulsky Susan

Chief Commercial Officer, MRD

C-Level
Sell5.0K$19.00$95K

Jun 4, 2026

5 months ago

Bobulsky Susan

Chief Commercial Officer, MRD

C-Level
Sell11.0K$18.00$198K

Jun 4, 2026

5 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell253.4K$-39741.00$0

Jun 4, 2026

5 months ago

Lo Francis

Chief People Officer

C-Level
Sell39.7K$17.49$695K

May 18, 2026

6 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell256.7K$-3115.00$0

May 18, 2026

6 months ago

Piskel Kyle

CFO

CFO
Sell3.1K$13.04$41K

Apr 27, 2026

6 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell377.8K$-19037.00$0

Apr 27, 2026

6 months ago

Rubinstein Julie

Pres, COO

COO
Sell19.0K$14.23$271K

Apr 22, 2026

7 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell382.1K$-57180.00$0

Apr 22, 2026

7 months ago

Rubinstein Julie

Pres, COO

COO
Sell57.2K$13.96$798K

Apr 17, 2026

7 months ago

Rubinstein Julie

Pres, COO

COO
Sell69.1K$14.60$1.01M

Apr 17, 2026

7 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell395.1K$-69061.00$0

Apr 14, 2026

7 months ago

Rubinstein Julie

Pres, COO

COO
Sell57.2K$14.45$826K

Apr 14, 2026

7 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell408.2K$-57180.00$0

Apr 9, 2026

7 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell421.2K$-57180.00$0

Apr 9, 2026

7 months ago

Rubinstein Julie

Pres, COO

COO
Sell57.2K$13.26$758K

Apr 8, 2026

7 months ago

Robins Harlan S

Chief Scientific Officer

C-Level
Sell10.0K$14.85$149K

Apr 8, 2026

7 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell273.7K$-22564.00$0

Apr 8, 2026

7 months ago

Lo Francis

Chief People Officer

C-Level
Sell22.6K$15.07$340K

Apr 6, 2026

7 months ago

Rubinstein Julie

Pres, COO

COO
Sell69.1K$14.34$991K

Apr 6, 2026

7 months ago

Robins Chad M

CEO, COB

CEO
Sell120.6K$14.65$1.77M

Apr 6, 2026

7 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell2.18M$-120595.00$0

Apr 1, 2026

7 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell447.2K$-38120.00$0

Apr 1, 2026

7 months ago

Rubinstein Julie

Pres, COO

COO
Sell38.1K$14.53$554K

Mar 27, 2026

7 months ago

Rubinstein Julie

Pres, COO

COO
Sell57.2K$13.14$751K

Mar 27, 2026

7 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell455.9K$-57180.00$0

Mar 24, 2026

8 months ago

Rubinstein Julie

Pres, COO

COO
Sell57.2K$14.03$802K

Mar 24, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell468.9K$-57180.00$0

Mar 19, 2026

8 months ago

Rubinstein Julie

Pres, COO

COO
Sell57.2K$13.46$770K

Mar 19, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell481.9K$-57180.00$0

Mar 11, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell507.9K$-179703.00$0

Mar 11, 2026

8 months ago

Robins Chad M

CEO, COB

CEO
Sell470.2K$13.17$6.19M

Mar 11, 2026

8 months ago

Robins Harlan S

Chief Scientific Officer

C-Level
Sell470.3K$13.17$6.19M

Mar 11, 2026

8 months ago

Piskel Kyle

CFO

CFO
Sell18.7K$13.17$246K

Mar 11, 2026

8 months ago

Benzeno Sharon

Chief Commercial Ofc Imm Med

C-Level
Sell63.1K$13.17$831K

Mar 11, 2026

8 months ago

Bobulsky Susan

Chief Commercial Officer, MRD

C-Level
Sell41.3K$13.17$544K

Mar 11, 2026

8 months ago

Lo Francis

Chief People Officer

C-Level
Sell30.6K$14.08$431K

Mar 11, 2026

8 months ago

Griffin Michelle Renee

Dir

Director
Sell15.4K$13.91$214K

Mar 11, 2026

8 months ago

Rubinstein Julie

Pres, COO

COO
Sell179.7K$13.21$2.37M

Mar 6, 2026

8 months ago

Rubinstein Julie

Pres, COO

COO
Sell81.3K$14.90$1.21M

Mar 6, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell643.5K$-81342.00$0

Mar 5, 2026

8 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell324.5K$-38074.00$0

Mar 5, 2026

8 months ago

Lo Francis

Chief People Officer

C-Level
Sell38.1K$15.09$575K

Mar 3, 2026

8 months ago

Griffin Michelle Renee

Dir

Director
Sell48.0K$15.30$735K

Mar 3, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell15.4K$-48044.00$0

Mar 3, 2026

8 months ago

Rubinstein Julie

Pres, COO

COO
Sell92.8K$16.09$1.49M

Mar 2, 2026

8 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell1.16M$-24233.00$0

Mar 2, 2026

8 months ago

Robins Harlan S

Chief Scientific Officer

C-Level
Sell24.2K$16.19$392K

Feb 27, 2026

8 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell1.93M$-524998.00$0

Feb 27, 2026

8 months ago

Robins Chad M

CEO, COB

CEO
Sell525.0K$15.85$8.32M
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
ADPT Buy Conviction0%
Industry Rank#283 of 563
Volume Contribution0.6%
Total Industry Activity$16.73B

ADPT has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. ADPT ranks #283 in insider activity out of 563 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for ADPT

Over the last 90 days, corporate insiders at ADPT (ADPT) engaged in a total of 100 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 60 were sales. The total volume of insider trading reached $102.03M.

The net insider activity for ADPT shows a net selling bias of $102.03M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Robins Chad M (CEO, COB), who traded 600.0K shares valued at $14.88M on Aug 17, 2026.

Live Market News & Developments
Aggregated real-time headlines for ADPT (ADPT)
6 updates

Adaptive Biotechnologies (ADPT) Stock Could Be 26% Above Fair Value Despite Guideline Update

Yahoo Finance55d ago

A cancer test can detect 1 cell in 1 million healthy cells. New research will examine its role in treatment decisions.

Stock TitanYesterday

ADPT - Adaptive Biotechnologies Corp Stock Price and Quote

Finviz175d ago

Adaptive Biotechnologies (ADPT) Stock Sees Modest Fair Value Lift On MRD Optimism

Yahoo Finance42d ago

Adaptive Biotechnologies (ADPT) Stock Looks Reasonable As Cash Flow Recovery Takes Shape

Simply Wall St9d ago

Adaptive Biotechnologies (NASDAQ:ADPT) Stock: Insider Susan Bobulsky Sells 1,875 Shares

MarketBeat5d ago

FAQs About ADPT Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for ADPT.

Based on SEC Form 4 disclosures, the Insider Confidence Score for ADPT is currently 15/100, which reflects a heavy distribution bias. This calculation accounts for a total of 0 purchases and 60 sales by company executives over the last 90 days.

The CEO Conviction Index for ADPT is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.